An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge

Traditional protein-based vaccine approaches to COVID-19 were overshadowed by the new mRNA and adenoviral vector vaccine approaches which were first to receive marketing authorization. The current study tested for the first time in repurposed aged (median 15.4 years) cynomolgus macaques, a novel Adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda-Okubo, Yoshikazu, Li, Lei, André, Greiciely, Leong, King Ho, Howerth, Elizabeth W., Bebin-Blackwell, Anne G., Ross, Ted M., Petrovsky, Nikolai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277844/
https://www.ncbi.nlm.nih.gov/pubmed/37355452
http://dx.doi.org/10.1016/j.vaccine.2023.06.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277844/
https://www.ncbi.nlm.nih.gov/pubmed/37355452
http://dx.doi.org/10.1016/j.vaccine.2023.06.063

Ejemplares similares